Bonefos Approval Contingent On Study Results Expected In 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will not approve the breast cancer bone metastases treatment before seeing confirmatory efficacy results from the National Surgical Adjuvant Breast & Bowel Project B-34 study. The drug was deemed "approvable" in January.